Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease ; volume:23 ; number:1 ; day:4 ; month:7 ; year:2024 ; pages:1-11 ; date:12.2024
Cardiovascular diabetology ; 23, Heft 1 (4.7.2024), 1-11, 12.2024
- Creator
-
Chen, Qingling
Hu, Pingping
Hou, Xiaoxue
Sun, Ye
Jiao, Mengfan
Peng, linya
Dai, Zixing
Yin, Xizhi
Liu, Rui
Li, Yuwen
Zhu, Chuanlong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-024-02343-7
- URN
-
urn:nbn:de:101:1-2409231257225.834192033010
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chen, Qingling
- Hu, Pingping
- Hou, Xiaoxue
- Sun, Ye
- Jiao, Mengfan
- Peng, linya
- Dai, Zixing
- Yin, Xizhi
- Liu, Rui
- Li, Yuwen
- Zhu, Chuanlong
- SpringerLink (Online service)
Other Objects (12)
Association between triglyceride–glucose index and nonalcoholic fatty liver disease in type 2 diabetes mellitus
Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Association between the Triglyceride–Glucose Index and Non-Alcoholic Fatty Liver Disease in patients with Atrial Fibrillation
Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity
Phosphorylation: new star of pathogenesis and treatment in steatotic liver disease
Integrating social nutrition principles into the treatment of steatotic liver disease
Opportunistic assessment of steatotic liver disease in lung cancer screening eligible individuals
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
The impact of steatotic liver disease on coronary artery disease through changes in the plasma lipidome
Correlation between the triglyceride-glucose index and the onset of atrial fibrillation in patients with non-alcoholic fatty liver disease
Association between triglyceride–glucose index and nonalcoholic fatty liver disease in type 2 diabetes mellitus
Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Association between the Triglyceride–Glucose Index and Non-Alcoholic Fatty Liver Disease in patients with Atrial Fibrillation
Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity
Phosphorylation: new star of pathogenesis and treatment in steatotic liver disease
Integrating social nutrition principles into the treatment of steatotic liver disease
Opportunistic assessment of steatotic liver disease in lung cancer screening eligible individuals
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
The impact of steatotic liver disease on coronary artery disease through changes in the plasma lipidome
Correlation between the triglyceride-glucose index and the onset of atrial fibrillation in patients with non-alcoholic fatty liver disease
Association between triglyceride–glucose index and nonalcoholic fatty liver disease in type 2 diabetes mellitus
Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Association between the Triglyceride–Glucose Index and Non-Alcoholic Fatty Liver Disease in patients with Atrial Fibrillation
Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity
Phosphorylation: new star of pathogenesis and treatment in steatotic liver disease
Integrating social nutrition principles into the treatment of steatotic liver disease
Opportunistic assessment of steatotic liver disease in lung cancer screening eligible individuals
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
The impact of steatotic liver disease on coronary artery disease through changes in the plasma lipidome